assess the incidence of each risk factor in our community as a predictor of acute myocardial infarction. Methods: Fifty patients (Pts) admitted to the main university hospital with acute myocardial Infarction were studied. All risk factors were recorded as well as echocardiographic measurements. Metabolic syndrome components were defined as detailed in the ATP III report: (1) waist circumference >102 cm in men and >88 cm in women, (2) fasting triglycerides P150 mg/dl, (3) HDL cholesterol <40 mg/dl in men and <50 mg/dl in women, (4) blood pressure P130/85 mmHg, and (5) fasting -glucose P110 mg/ dl. Participants with at least three of these components were determined to have the MS. Results: MS was present in 27 pts (54%). The incidence of different risk factors in the 50 pts: Family history of any point as before age 60 as coronary disease, sudden death, diabetes, Ht was present in 36 pts (72%), smoking (current or stopped less than 6 months 38 pts (76%)).
Purpose: To investigate whether the ST changes in the aVR lead on 12lead ECG can be used to identify infarct-related artery (IRA) in patients with acute inferior ST-segment elevation myocardial infarction. Methods: The ECG features were studied in 56 patients with acute inferior myocardial infarction where IRA was confirmed by coronary angiography. Results: Right coronary artery (RCA) and the left circumflex coronary artery (LCX) were identified as IRA in 41 and 15 patients, respectively. ST depression in aVR P0.1 mV was found in 9 (60%) patients who had LCX as the IRA, and in 5 (12.2%) (2p < 0.001) patients with RCA as IRA. Using ST segment depression P0.1 mV in aVR as a criterion, the sensitivity and specificity in differentiating LCX as IRA was 60% and 87.80%, respectively. Conclusions: ST depression in aVR is common in patients with LCXrelated acute inferior myocardial infarction. The ST changes in this lead are associated with an excellent specificity and a good sensitivity in differentiating LCX from RCA as the IRA.
http://dx.doi.org/10. 1016/j.ehj.2013.12.068 Succesful transcatheter closure of perimembranous ventricular septal defect with inlet extension using ADOI Mashail Alobaidan, Jassim Al hudaithi Pediatric Cardiology Division, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Introduction: Transcatheter closure of perimembranous ventricular septal defect (PM VSD) is abandoned in many center and in some became restricted to certain age and criteria because of the risk of complete heart block (CHB). The risk of damaging the tricuspid valve (TV) in the presence of inlet extension is another risk. I am presenting successful closure of such defect using Amplatzer occlude device for PDA with reasonable follow up period in Prince Sultan Cardiac Center PSCC. Method: Through 2011 4 patients underwent transcatheter closure of PM VSD with inlet extension , all patients were consented and procedure were done under general anesthesia , Transesophageal echocardiography was done in all, one has 3D assessment Hemodynamics were assessed pre procedural, A-V loop was applied in 2 patients, ADOI were used in all, heparin and antibiotics were giving during and 24 hr post procedure, 3 patients were extubated same day and one the following day, all patients were kept on aspirin for 6 months. Result: Median age 17 kg , 3 female and 1 male , median age 7 year, Median ventilatory duration is one day, Median hospital stay is 2 days, Median Follow up is 10 months, No immediate or early complication or deaths, normal ECG immediately and during follow up period , normal Echocardiography with no residual leak during follow up period. Conclusion: In selected patients with PM VSD and inlet extension ADOI device can be used safely and effectively to close the defect with no immediate or early complications. 
